<DOC>
	<DOCNO>NCT00035516</DOCNO>
	<brief_summary>The purpose clinical research study learn BMS-247550 shrink slow growth cancer patient non-small cell lung cancer fail first-line platinum base chemotherapy . The safety treatment also study .</brief_summary>
	<brief_title>A Phase II Study Epothilone Analog BMS-247550 Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<criteria>Histologically cytologically confirm nonsmall cell lung cancer Bidimensionally measurable disease Progressed follow therapy one prior cisplatin carboplatin base chemotherapy regimen Stage III IV metastatic recurrent disease Adequate hematologic function define : absolute neutrophil =/ &gt; 2,000/mm3 , platelet &gt; 125,000/mm3 Adequate hepatic function define : serum bilirubin=/ &lt; 1.5 time upper institutional limit normal , ALT =/ &lt; 2.5 time upper institutional limit normal ( =/ &lt; 5 time upper institutional limit normal hepatic metastasis present Adequate renal function define : serum creatine =/ &lt; 1.5 time upper limit normal Adequate recovery recent surgery , chemotherapy radiation therapy . At least one week must elapse time minor surgery , least 3 week major surgery , chemotherapy radiation therapy Life expectancy least 12 week ECOG performance status 01 At least 18 year old Willing able give write informed consent Accessible treatment followup . Patients enrol trial must treat participate center Women Child Bearing Potential ( WOCP ) must negative serum urine pregnancy test ( minimum sensitivity IU/L equivalent unit HCG ) within 72 hour prior start study medication . WOCBP include female experienced menarche undergone successful surgical sterilization ( hysterectomy , bilateral tubal ligation bilateral oophorectomy ) postmenopausal [ define amenorrhea=/ &gt; 12 consecutive month ; woman hormone replacement therapy ( HRT ) document serum follicle stimulate hormone ( FSH ) level &gt; 35mIU/mL ] . Even woman use oral , implanted , injectable intrauterine device barrier method ( diaphragm , condom , spermicide ) prevent pregnancy practice abstinence partner sterile ( e.g. , vasectomy ) , consider child bear potential . Exclusion Criteria More one prior chemotherapy regimen Stage IIIB IV metastatic recurrent disease . Prior adjuvant neoadjuvant chemotherapy allow . Patients candidate curative resection . CTC Grade 2 great neuropathy ( motor sensory ) Known brain metastasis Prior radiation must include major bone marrow contain area ( pelvis , lumbar , spine ) must contain target lesion measurable lesion . A recovery period least 3 week completion radiotherapy require prior enrollment . Myocardial infarction , unstable angina , history congestive heart failure within six month study therapy Pregnant breastfeeding woman , sexually active woman childbearing potential use adequate method birth control . Sexually active fertile men , whose partner woman childbearing potential , unless use adequate method birth control Serious intercurrent infection , nonmalignant medical illness control whose control may jeopardize complication therapy Psychiatric disorder condition render patient incapable complying requirement protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>